Psyence Group
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
121 Richmond St W Ph Ste1300, Toronto, O...Phone Number
(416) 477-1708Website
www.psyencebiomed.comRevenue
<$5 MillionStock Symbol
PBMIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Psyence Group
Psyence Biomed is the worlds first life science biotechnology company traded on the Nasdaq (NASDAQ:PBM) focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicines. The name Psyence combines the words psychedelics and science to affirm Psyence Biomeds commitment to an evidence-based approach to innovation as it works to develop safe and effective, nature-derived psychedelic therapeutics to treat a broad range of mental health disorders. Psyence Biomed is initially focused on mental health disorders in the context of Palliative Care.Explore more
Psyence Group Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Psyence Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Psyence Group launches new products
Earning: See what the market has to say on Psyence Group recently announced quarterly report
Psyence Group, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Psyence Group has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Psyence Group
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Psyence Group had a recent Job posting/layoffs
Check out if Psyence Group is spiking on competitors!
Funding: Get notified immidiatlly once Psyence Group has new funding data
Recommended Actions
Find VP level buyers at Psyence Group
Find more new buyers
Company Profile Activity
Activity Insights
Psyence Group is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Psyence Group is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Psyence Group.
Psyence Group financials insights
Gather financial insights about Psyence Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$10M
Most Recent Scoops
Person-Based
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Funding
Funding
Psyence Group News & Media
Psyence BioMed Announces Strategic Ibogaine Investment
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchangePsyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
Texas-based company is designed to coordinate U.S. development, pharmaceutical-grade supply and potential clinical sponsorship activities through a dedicated Psyence BioMed entity Texas-based company is designed to coordinate U.S. development, pharmaceutical-grade supply and potential clinical sponsorship activities through a dedicated Psyence BioMed entityPsyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has builtPsyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today announced that members of its executive leadership team will travel to the United States in the coming weeks to meet with researchers, institutions, industry leaders, and government stakeholders involved in advancing psych
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Psyence Group
Sign Up For FreeTo access detailed company insights
Psyence Biomed is the worlds first life science biotechnology company traded on the Nasdaq (NASDAQ:PBM) focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicines. The name Psyence combines the words psychedelics and science to affirm Psyence Biomeds commitment to an evidence-based approach to... Read More
